Literature DB >> 9726055

HPV typing and testing in gynaecological pathology: has the time come?

C J Meijer1, T J Helmerhorst, L Rozendaal, J C van der Linden, F J Voorhorst, J M Walboomers.   

Abstract

Mesh：

Year:  1998        PMID： 9726055     DOI： 10.1046/j.1365-2559.1998.00436.x

Source DB:  PubMed          Journal:  Histopathology        ISSN： 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  12 in total

1.  Novel method for detection, typing, and quantification of human papillomaviruses in clinical samples.

Authors:  K W Hart; O M Williams; N Thelwell; A N Fiander; T Brown; L K Borysiewicz; C M Gelder
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

2.  Quantitative screening of single copies of human papilloma viral DNA without amplification.

Authors:  Jiangwei Li; Ji-Young Lee; Edward S Yeung
Journal:  Anal Chem       Date:  2006-09-15       Impact factor: 6.986

3.  Prevalence of HPV infection among Greek women attending a gynecological outpatient clinic.

Authors:  Petroula Stamataki; Athanasia Papazafiropoulou; Ioannis Elefsiniotis; Margarita Giannakopoulou; Hero Brokalaki; Eleni Apostolopoulou; Pavlos Sarafis; George Saroglou
Journal:  BMC Infect Dis       Date:  2010-02-15       Impact factor: 3.090

4.  Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control.

Authors:  Hextan Y S Ngan; Suzanne M Garland; Neerja Bhatla; Sonia R Pagliusi; Karen K L Chan; Annie N Y Cheung; Tang-Yuan Chu; Efren J Domingo; You Lin Qiao; Jong Sup Park; Eng Hseon Tay; Wisit Supakarapongkul
Journal:  J Cancer Epidemiol       Date:  2011-04-13

5.  Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing.

Authors:  P Vassilakos; P Petignat; M Boulvain; A Campana
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

6.  A simplified and reliable HPV testing of archival Papanicolaou-stained cervical smears: application to cervical smears from cancer patients starting with cytologically normal smears.

Authors:  M V Jacobs; D Zielinski; C J Meijer; R P Pol; F J Voorhorst; F A de Schipper; A P Runsink; P J Snijders; J M Walboomers
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

7.  Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women.

Authors:  C Clavel; M Masure; J P Bory; I Putaud; C Mangeonjean; M Lorenzato; P Nazeyrollas; R Gabriel; C Quereux; P Birembaut
Journal:  Br J Cancer       Date:  2001-06-15       Impact factor: 7.640

8.  Human papillomavirus oncogenic expression in the dysplastic portio; an investigation of biopsies from 190 cervical cones.

Authors:  I Kraus; T Molden; L E Ernø; H Skomedal; F Karlsen; B Hagmar
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

9.  Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.

Authors:  C Clavel; J Cucherousset; M Lorenzato; S Caudroy; J M Nou; P Nazeyrollas; M Polette; J-P Bory; R Gabriel; C Quereux; P Birembaut
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

10.  Prevalence and determinants of HPV infection among Colombian women with normal cytology.

Authors:  M Molano; H Posso; E Weiderpass; A J C van den Brule; M Ronderos; S Franceschi; C J L M Meijer; A Arslan; N Munoz
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.